Incidence, clinical and epidemiological risk factors, and outcome of drug-induced hepatitis due to antituberculous agents in new tuberculosis cases
Drug-induced hepatitis (DIH) is an important issue in tuberculosis (TB) treatment. We intend
to assess the incidence, risk factors, and outcome of hepatitis due to anti-TB drugs. The …
to assess the incidence, risk factors, and outcome of hepatitis due to anti-TB drugs. The …
High rates of drug-induced liver injury in people living with HIV coinfected with tuberculosis (TB) irrespective of antiretroviral therapy timing during antituberculosis …
K Naidoo, R Hassan-Moosa, P Mlotshwa… - Clinical Infectious …, 2020 - academic.oup.com
Background New onset or worsening drug-induced liver injury challenges coinfected
patients on antiretroviral therapy (ART) initiation during antituberculosis (TB) treatment …
patients on antiretroviral therapy (ART) initiation during antituberculosis (TB) treatment …
[HTML][HTML] Hepatotoxicity induced by isoniazid in patients with latent tuberculosis infection: a meta-analysis
TJ Oscanoa, X Vidal, J Luque, DI Julca… - … and hepatology from …, 2023 - ncbi.nlm.nih.gov
Aim: The aim of the present study was to conduct a meta-analysis of the frequency of
isoniazid-induced liver injury (INH-ILI) in patients receiving isoniazid (INH) preventative …
isoniazid-induced liver injury (INH-ILI) in patients receiving isoniazid (INH) preventative …
[引用][C] Hepatotoxicity and tuberculosis treatment outcomes in chronic liver
BDE MD, SKB MD - 2023 - europepmc.org
BACKGROUND: The treatment of tuberculosis (TB) is known to cause liver injury, however,
there is limited data to guide optimal treatment for patients with chronic liver disease …
there is limited data to guide optimal treatment for patients with chronic liver disease …
[HTML][HTML] Time of liver function abnormal identification on prediction of the risk of anti-tuberculosis-induced liver injury
D Huang, J Peng, L Lei, Y Chen, Z Zhu… - Journal of Clinical …, 2023 - ncbi.nlm.nih.gov
Methods A total of 399 patients without high-risk factors for liver damage at baseline and
who experienced LFT abnormal during the 6 months of first-line anti-TB treatment were …
who experienced LFT abnormal during the 6 months of first-line anti-TB treatment were …
Clinical and biochemical profile of tuberculosis in patients with liver cirrhosis
P Sharma, P Tyagi, V Singla, N Bansal, A Kumar… - Journal of clinical and …, 2015 - Elsevier
Introduction There is paucity of data on tuberculosis and antituberculous therapy (ATT)
induced hepatotoxicity in patients with chronic liver disease. Aim To study demographic …
induced hepatotoxicity in patients with chronic liver disease. Aim To study demographic …
[HTML][HTML] Diabetes is a risk factor for pulmonary tuberculosis: a case-control study from Mwanza, Tanzania
Background Diabetes and TB are associated, and diabetes is increasingly common in low-
income countries where tuberculosis (TB) is highly endemic. However, the role of diabetes …
income countries where tuberculosis (TB) is highly endemic. However, the role of diabetes …
[PDF][PDF] Anti-tuberculosis drug induced hepatotoxicity: A study from Himalayan region
V Gupta, TC Guleria, S Kumar, S Sharma… - Int J Res Med …, 2022 - researchgate.net
Background: Tuberculosis (TB) is the infection of global health concern. The management of
TB is a 6-month course of anti-TB drugs. Compliance is crucial for curing TB. Adverse effects …
TB is a 6-month course of anti-TB drugs. Compliance is crucial for curing TB. Adverse effects …
Metformin use and post-exposure incident tuberculosis: a nationwide tuberculosis-contact cohort study in Taiwan
SW Pan, JY Feng, YF Yen, FY Chuang… - ERJ Open …, 2020 - Eur Respiratory Soc
Patients with diabetes mellitus are susceptible to active tuberculosis (TB) and latent TB
infection (LTBI)[1–3]. Close contact with patients with infectious TB is associated with an …
infection (LTBI)[1–3]. Close contact with patients with infectious TB is associated with an …